Clinical Research Paper Executive Summary

What a good one includes

• A clear statement of the study’s primary hypothesis and the specific clinical question it aims to answer.
• A breakdown of the study design, including patient population size, randomization, control groups, and trial phases.
• The primary and secondary endpoints with actual statistical values, such as p-values, hazard ratios, or confidence intervals.
• An objective assessment of the study's limitations, including potential sources of bias, sample size constraints, or funding conflicts.
• Actionable insights detailing how these findings translate to real-world patient care, treatment protocols, or medical technology development.
• A brief outlook on what these results mean for ongoing research or upcoming clinical trials in the field.

Common mistakes to avoid

• Regurgitating the abstract verbatim instead of analyzing the deeper methodology and data quality of the full paper.
• Omitting statistical significance markers like p-values or confidence intervals, which makes the summary look scientifically weak to employers.
• Overlooking the study's limitations and conflicts of interest, leading to an overly optimistic and unbalanced interpretation of the results.
• Failing to explain the practical implications of the clinical findings for day-to-day medical practice or industry strategy.

Frequently asked questions